138 related articles for article (PubMed ID: 32810863)
1. Systemic Inflammation Is Associated with Oncological Outcome in Patients with High-Grade Myxofibrosarcoma of the Extremities: A Retrospective Analysis.
Sambri A; Zucchini R; Giannini C; Cevolani L; Fiore M; Spinnato P; Bianchi G; Donati DM; De Paolis M
Oncol Res Treat; 2020; 43(10):531-538. PubMed ID: 32810863
[TBL] [Abstract][Full Text] [Related]
2. Grading in Myxofibrosarcoma of the Extremities Can Predict Survival and Local Control.
Sambri A; Tuzzato G; Spinnato P; De Paolis M; Donati DM; Bianchi G
Oncol Res Treat; 2020; 43(5):189-195. PubMed ID: 32268331
[TBL] [Abstract][Full Text] [Related]
3. Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities?
Sambri A; Spinnato P; Bazzocchi A; Tuzzato GM; Donati D; Bianchi G
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e181-e186. PubMed ID: 31111597
[TBL] [Abstract][Full Text] [Related]
4. Soft tissue myxofibrosarcoma: A clinico-pathological analysis of a series of 75 patients with emphasis on the epithelioid variant.
Scoccianti G; Ranucci V; Frenos F; Greto D; Beltrami G; Capanna R; Franchi A
J Surg Oncol; 2016 Jul; 114(1):50-5. PubMed ID: 27076198
[TBL] [Abstract][Full Text] [Related]
5. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival.
Lin CN; Chou SC; Li CF; Tsai KB; Chen WC; Hsiung CY; Yen CF; Huang HY
J Surg Oncol; 2006 Mar; 93(4):294-303. PubMed ID: 16496357
[TBL] [Abstract][Full Text] [Related]
7. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Choi ES; Kim HS; Han I
Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical factors impacting recurrence in myxofibrosarcoma.
Chen W; Ye M; Sun Y; Wei Y; Huang Y
Sci Rep; 2024 Feb; 14(1):3903. PubMed ID: 38365844
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and outcomes of patients with myxofibrosarcoma.
Look Hong NJ; Hornicek FJ; Raskin KA; Yoon SS; Szymonifka J; Yeap B; Chen YL; DeLaney TF; Nielsen GP; Mullen JT
Ann Surg Oncol; 2013 Jan; 20(1):80-6. PubMed ID: 22890594
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Local Recurrence in Patients With Myxofibrosarcoma.
Odei B; Rwigema JC; Eilber FR; Eilber FC; Selch M; Singh A; Chmielowski B; Nelson SD; Wang PC; Steinberg M; Kamrava M
Am J Clin Oncol; 2018 Sep; 41(9):827-831. PubMed ID: 28640064
[TBL] [Abstract][Full Text] [Related]
11. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
[TBL] [Abstract][Full Text] [Related]
13. MRI Features as Prognostic Factors in Myxofibrosarcoma: Proposal of MRI Grading System.
Spinnato P; Clinca R; Vara G; Cesari M; Ponti F; Facchini G; Longhi A; Donati DM; Bianchi G; Sambri A
Acad Radiol; 2021 Nov; 28(11):1524-1529. PubMed ID: 32928636
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathologic examination of myxofibrosarcoma. Do surgical margins significantly affect local recurrence rates in this infiltrative sarcoma subtype?
Dadrass F; Gusho C; Yang F; Culvern C; Bloom J; Fillingham Y; Colman M; Gitelis S; Blank A
J Surg Oncol; 2021 Feb; 123(2):489-496. PubMed ID: 33125727
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer.
Seong MK
J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054
[TBL] [Abstract][Full Text] [Related]
16. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
[TBL] [Abstract][Full Text] [Related]
17. Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy.
Boughzala-Bennadji R; Stoeckle E; Le Péchoux C; Méeus P; Honoré C; Attal J; Duffaud F; De Pinieux G; Bompas E; Thariat J; Leroux A; Bertucci F; Isambert N; Delcambre C; Blay JY; Sunyach MP; Coindre JM; Sargos P; Penel N; Bonvalot S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):399-406. PubMed ID: 30191871
[TBL] [Abstract][Full Text] [Related]
18. Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Yada Y; Hagi T; Sudo A
PLoS One; 2017; 12(7):e0181787. PubMed ID: 28727824
[TBL] [Abstract][Full Text] [Related]
19. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant.
Mentzel T; Calonje E; Wadden C; Camplejohn RS; Beham A; Smith MA; Fletcher CD
Am J Surg Pathol; 1996 Apr; 20(4):391-405. PubMed ID: 8604805
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
Mbeutcha A; Shariat SF; Rieken M; Rink M; Xylinas E; Seitz C; Lucca I; Mathieu R; Rouprêt M; Briganti A; Karakiewicz PI; Klatte T
Urol Oncol; 2016 Nov; 34(11):483.e17-483.e24. PubMed ID: 27646875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
